Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hylapharm
AddedFeb 15, 2024
UpdatedJun 18, 2026
Hylapharm

Hylapharm

HylaPharm: A university spinout developing targeted cancer therapies and innovative drugs.

HQ
Lawrence, KS, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

HylaPharm, a university spinout company, is dedicated to developing targeted cancer therapies and innovative drugs. Founded with a mission to revolutionize cancer treatment, HylaPharm offers products such as HylaPlat, a new cancer drug that has demonstrated efficacy in multiple mouse models and in several dogs with large, naturally occurring cancers. The company's core focus is on reversing tumor-induced immune suppression to enhance the immune system's response to "cold" tumors, making them "hot" and more treatable.

Notable figures affiliated with HylaPharm include leading researchers and oncologists from its founding university. The company has attracted significant interest from investors focused on groundbreaking medical technologies. Key achievements include promising preclinical results in both animal models and real-world applications in pet dogs. HylaPharm's innovative approach has the potential to significantly impact cancer treatment protocols, offering new hope for both human and veterinary oncology.

Hylapharm - Similar Companies

WayPath Pharma logo

WayPath Pharma

waypathpharma.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Elias Animal Health logo

Elias Animal Health

Onchilles Pharma logo

Onchilles Pharma

Animal Life Sciences logo

Animal Life Sciences

OncoSpherix logo

OncoSpherix

oncospherix.com

Sisu Pharma logo

Sisu Pharma

sisupharma.com

Glycyx logo

Glycyx

glycyx.com

HiberCell logo

HiberCell

hibercell.com

Trio Pharmaceuticals logo

Trio Pharmaceuticals

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Umoja Biopharma logo

Umoja Biopharma

Palm Therapeutics logo

Palm Therapeutics

PhytoCeutica logo

PhytoCeutica

phytoceutica.com

Zenopharm logo

Zenopharm

Hylapharm - Quick Facts

Who are Hylapharm's competitors?

Companies similar to Hylapharm include WayPath Pharma, Novita Pharmaceuticals, Elias Animal Health and Onchilles Pharma.

When was Hylapharm founded?

Hylapharm was founded in 2010.

Where is Hylapharm's headquarters located?

Hylapharm's headquarters is located in Lawrence, KS, US.

When was Hylapharm's last funding round?

Hylapharm's most recent funding round was for $500k (USD) in December 2014.

How much has Hylapharm raised to-date?

As of Dec 23, 2014, Hylapharm has raised a total of $500k (USD).

How many employees does Hylapharm have?

Hylapharm has 6 employees as of Feb 4, 2024.

Hylapharm - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
Tags
  • Data
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research